SNMMI backs delayed uranium export ban | Total-body PET allows real-time video capture of bodily functions | Study finds racial gaps in dementia drug prescriptions
January 21, 2020
CONNECT WITH SNMMI LinkedInFacebookTwitterYoutube
SNMMI SmartBrief
News for nuclear medicine and molecular imaging professionals
SIGN UP ⋅   SHARE
Top Story
SNMMI backs delayed uranium export ban
SNMMI expressed support for the US Department of Energy's postponement of a ban on export licenses for highly enriched uranium used in producing medical radioisotopes amid an inadequate supply of molybdenum-99. "The two-year delay is a very positive development for patients whose care is facilitated by this important nuclear medicine isotope," SNMMI said.
FreightWaves (1/20) 
LinkedIn Twitter Facebook Email
Clinical News & Research
Total-body PET allows real-time video capture of bodily functions
Researchers who used the total-body EXPLORER PET scanner and advanced data reconstruction approaches were able to produce a video providing clear and real-time capture of radiotracer movement to the heart and the rest of the body, as well as cardiac contraction changes and end-systolic and end-diastolic phase delineation. The findings were published in the Proceedings of the National Academy of Sciences.
Medical Xpress/News release (1/20) 
LinkedIn Twitter Facebook Email
Study finds racial gaps in dementia drug prescriptions
Asians with dementia had a 14% lower likelihood of being given anti-dementia drug prescriptions and received these drugs for 15 fewer days annually on average, compared with whites, researchers reported in the journal Clinical Epidemiology. The findings also showed that antipsychotic drugs were prescribed 27 days longer among blacks and 17 days longer among Asians, compared with whites.
Medical Xpress/News release (1/20) 
LinkedIn Twitter Facebook Email
Novel T-cell may be used in treating various cancers
A study in the journal Nature Immunology showed that a T-cell with a receptor targeting the MR1 molecule was able to destroy blood, breast, bone, cervical, colon, kidney, lung, ovarian, prostate and skin cancer cells without affecting normal tissues. The findings suggest that the approach may be used in treating all cancers but more studies are still needed, researchers said.
BBC (1/20) 
LinkedIn Twitter Facebook Email
Industry Report
2 AZ cancer drugs granted orphan status from FDA
Two cancer drugs by AstraZeneca, lung cancer treatment Imfinzi and tremelimumab, have both received the FDA's orphan drug designation. Both drugs are currently being tested as a combo therapy in patients with liver cancer in the company's late-stage study dubbed Himalaya.
Seeking Alpha (1/20),  Bloomberg (tiered subscription model) (1/20) 
LinkedIn Twitter Facebook Email
Bridge Bio gains clearance for IND of EGFR-mutant NSCLC candidate
Bridge Biotherapeutics' investigational new drug application gained the FDA's clearance for BBT-176, its novel EGFR tyrosine kinase inhibitor, as a therapy for EGFR C797S–mutant non–small cell lung cancer. The biotech then plans to launch a dose-escalation study to assess BBT-176's anti-tumor efficacy, safety and tolerability while determining the treatment's maximum tolerated dose in its first-in-human study to be conducted in Korea.
Targeted Oncology (1/20) 
LinkedIn Twitter Facebook Email
News from the Field
Research highlights benefits of blockchain technology in radiology
Blockchain technology can be useful in radiological practices because its capabilities to distribute and store medical images are similar to picture archiving and communication systems, radiologists Morgan McBee and Chad Wilcox wrote in an article in the Journal of Digital Imaging. McBee and Wilcox cited four areas where blockchain technology can be used: monitoring of medical devices, improving artificial intelligence tools, sharing of medical images and enhancing research capabilities.
Health Imaging online (1/16) 
LinkedIn Twitter Facebook Email
Health Policy
FTC to closely scrutinize hospital mergers in 2020
Federal Trade Commission member Christine Wilson told a Council for Affordable Health Coverage event that horizontal hospital mergers will be under scrutiny in 2020, and some mergers could get an after-the-fact review to see whether they achieved cost and quality goals. Wilson said the FTC will continue to focus on competition, including seeking the repeal of state certificate-of-need laws and flexibility in scope-of-practice laws.
Healthcare Dive (1/17) 
LinkedIn Twitter Facebook Email
Advancing Health Care
EHR, claims data alone, combined useful for predicting hospitalization
Analytic tools that use EHR data, claims data or both had similar power in predicting hospitalizations over a six-month period, researchers reported in the American Journal of Managed Care. "Although our results suggest some utility to combining EHR and claims data to inform predictive model creation, we find that even in scenarios in which only EHR or claims data are available, strong performance can be achieved provided that a diverse collection of variable types is represented," researchers wrote.
EHR Intelligence (1/16) 
LinkedIn Twitter Facebook Email
From SNMMI
Last chance to register online for the 2020 SNMMI Mid-Winter and ACNM Annual Meeting
The 2020 SNMMI Mid-Winter and ACNM Annual Meeting begins Thursday. Arrive in Tampa ready to learn by completing your registration online now, then get ready to immerse yourself in an extensive educational program designed to give you practical clinical knowledge and to foster collaboration with colleagues and experts from around the world. Online pre-registration closes tonight at 11:59 p.m. ET. Register now.
LinkedIn Twitter Facebook Email
US Department of Energy delays implementation of ban on export of highly enriched uranium
The US Department of Energy has delayed the implementation of a ban on export of highly enriched uranium, helping to ensure adequate domestic supply of Tc-99m and preventing shortages that would negatively affect patients. Read more.
LinkedIn Twitter Facebook Email
Learn more about SNMMI:
SNMMI | Join/Renew Your Membership | MySNMMI | Meetings
Education | News & Publications | Advocacy | Donate
  
  
Tradition is the albatross around the neck of progress.
Bill Veeck,
professional baseball club executive, owner, promoter
LinkedIn Twitter Facebook Email
  
  
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.
 
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Editor  -  Doug Harris
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2020 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information